Enzyme-Linked DNA Displacement (ELIDIS) Assay for Ultrasensitive Electrochemical Detection of Antibodies

Francesco Ricci,Ana Díaz-Fernández,Simona Ranallo

DOI: https://doi.org/10.26434/chemrxiv-2023-ncq8c-v2

2023-11-21

Abstract:Here we report the development of a method for the electrochemical ultrasensitive detection of antibodies that couples the programmability and versatility of DNA-based systems with the sensitivity provided by enzymatic amplification. The platform, termed Enzyme-Linked DNA Displacement (ELIDIS), is based on the use of antigen-DNA conjugates that, upon the bivalent binding of a specific target antibody, induce the release of an enzyme-DNA hybrid strand from a preformed duplex. Such enzyme-DNA hybrid strand can then be electrochemically detected with a disposable electrode with high sensitivity. We applied ELIDIS to demonstrate the sensitive (limit of detection in the picomolar range), specific and multiplexed detection of five different antibodies including three clinically relevant ones. ELIDIS is also rapid (it only requires two reaction steps), works well in complex media (serum) and is cost-effective. A direct comparison with a commercial ELISA kit for the detection of Cetuximab demonstrates the promising features of ELIDIS as a point-of-care platform for antibodies detection.

Chemistry

What problem does this paper attempt to address?

This paper aims to develop a method for ultrasensitive electrochemical detection of antibodies, which combines the programmability of DNA systems and the high sensitivity of enzyme amplification techniques. The proposed platform is called the Enzyme - Linked DNA - Induced Displacement (ELIDIS) assay. Its core lies in the use of antigen - DNA conjugates. When specifically targeted antibodies bind bivalently, it triggers the release of enzyme - DNA hybrid strands in pre - formed double - stranded complexes. This hybrid strand can then be electrochemically detected on a disposable electrode with high sensitivity.

The specific objectives of the paper include:
1. **Improve detection sensitivity**: By combining the programmability of DNA systems and enzyme amplification techniques, ultrasensitive detection of low - concentration antibodies is achieved, with the limit of detection reaching the picomolar level.
2. **Achieve rapid detection**: The ELIDIS platform only requires two reaction steps, making the entire detection process fast and simple.
3. **Adapt to complex samples**: This method performs well in complex media (such as serum) and has wide applicability in practical applications.
4. **Cost - effectiveness**: Compared with traditional ELISA, the ELIDIS platform has lower cost, simpler operation, and is more suitable for point - of - care testing.
5. **Multi - target detection ability**: The ELIDIS platform can simultaneously detect multiple different antibodies, with high specificity and multiplex detection ability.

Through these objectives, the researchers hope that the ELIDIS platform can become a new, efficient, fast, economical antibody detection tool suitable for point - of - care testing.